Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.61 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.46 |
| ▸ | FDPS | P14324 | 3/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.42 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.41 |
| ▸ | LAP3 | P28838 | 1/20 | 0.41 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2098915 | 1.00 | DNM1 (0.61) | DNM1GGPS1FDPSFAAHS1PR2 | |
| Phosphoric Acid SCHEMBL7172946 | 0.91 | DNM1 (0.67) | DNM1GGPS1FDPSLAP3TRPM8 | |
| Phosphoric Acid SCHEMBL10532007 | 0.91 | DNM1 (0.75) | DNM1GGPS1FDPSLAP3TRPM8 | |
| Phosphoric Acid SCHEMBL7175095 | 0.91 | DNM1 (0.67) | DNM1GGPS1FDPSLAP3TRPM8 | |
| SCHEMBL7892230 | 0.91 | DNM1 (0.52) | DNM1GGPS1FDPSFAAHS1PR2 | |
| SCHEMBL5070634 | 0.91 | DNM1 (0.52) | DNM1GGPS1FDPSFAAHS1PR2 | |
| Phosphoric Acid SCHEMBL10529588 | 0.88 | DNM1 (0.71) | DNM1GGPS1FDPSLAP3TRPM8 | |
| Phosphoric Acid SCHEMBL7174626 | 0.88 | DNM1 (0.64) | DNM1GGPS1FDPSLAP3TRPM8 | |
| Phosphoric Acid SCHEMBL7172948 | 0.86 | DNM1 (0.61) | DNM1GGPS1FDPSS1PR2S1PR1 | |
| Phosphoric Acid SCHEMBL10529591 | 0.84 | DNM1 (0.65) | DNM1GGPS1FDPSLAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8163784-B2 | Biocidal compositions | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2012-04-24 | — | — | US | disclosed |
| US-20090203756-A1 | Biocidal Compositions | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203756-A1 | Biocidal Compositions | DBH, BBC3, C9 | DNM1 2691/4885GGPS1 4563/4885FDPS 4412/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.